KP Tissue Inc.
KPTSFOTCConsumer Defensive● Active
$9.48
+$0.26(+2.82%)
Market Cap$95011404
P/E Ratio—
52W High$9.48
52W Low$6.492
KP Tissue Inc. (KPTSF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
KPTSF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.16
Est. $0.17 · -4.3%
Revenue
$0.39B
Est. $0.40B · -2.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
KPTSF reports quarterly as a OTC-listed Household & Personal Products company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | $0.18 | — | — | — | $0.40B | — |
| ▼ Q2 FY2026 | May 14, 2026 | $0.17 | $0.16 | -4.3% | $0.39B | $0.40B | -2.5% |
| ▲ Q1 FY2026 | Feb 18, 2026 | $0.18 | $0.44 | +141.2% | $0.41B | $0.42B | -2.5% |
| ▲ Q3 FY2025 | Aug 13, 2025 | $0.09 | $0.19 | +111.8% | $0.39B | $0.56B | -29.4% |
| ▲ Q2 FY2025 | May 14, 2025 | $0.06 | $0.12 | +93.5% | $0.38B | $0.52B | -26.4% |
| ▼ Q1 FY2025 | Mar 5, 2025 | $0.11 | -$0.14 | -229.5% | $0.37B | $0.53B | -29.0% |
| ▲ Q4 FY2024 | Nov 13, 2024 | $0.10 | $0.15 | +48.1% | $0.39B | $0.52B | -26.2% |
| ▼ Q3 FY2024 | Aug 13, 2024 | $0.14 | $0.09 | -36.8% | $0.37B | $0.36B | +3.5% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
$0.18
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
$0.16
EPS Est.
$0.17
EPS Surpr.
-4.3%
Revenue
$0.39B
Q1 FY2026
Feb 18, 2026Beat
EPS Actual
$0.44
EPS Est.
$0.18
EPS Surpr.
+141.2%
Revenue
$0.41B
Q3 FY2025
Aug 13, 2025Beat
EPS Actual
$0.19
EPS Est.
$0.09
EPS Surpr.
+111.8%
Revenue
$0.39B
Q2 FY2025
May 14, 2025Beat
EPS Actual
$0.12
EPS Est.
$0.06
EPS Surpr.
+93.5%
Revenue
$0.38B
Q1 FY2025
Mar 5, 2025Miss
EPS Actual
-$0.14
EPS Est.
$0.11
EPS Surpr.
-229.5%
Revenue
$0.37B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
$0.15
EPS Est.
$0.10
EPS Surpr.
+48.1%
Revenue
$0.39B
Q3 FY2024
Aug 13, 2024Miss
EPS Actual
$0.09
EPS Est.
$0.14
EPS Surpr.
-36.8%
Revenue
$0.37B
No analyst estimates available for KPTSF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -4.3% | $8.35 | $8.44 | +1.08% |
| ▲ Q1 FY2026 | Feb 18, 2026 | +141.2% | $7.79 | $7.79 | +0.00% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +111.8% | $6.51 | $6.98 | +7.22% |
| ▲ Q2 FY2025 | May 14, 2025 | +93.5% | $6.07 | $6.07 | +0.00% |
| ▼ Q1 FY2025 | Mar 5, 2025 | -229.5% | $5.40 | $5.40 | +0.00% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +48.1% | $5.98 | $5.98 | +0.00% |
| ▼ Q3 FY2024 | Aug 13, 2024 | -36.8% | $6.34 | $6.34 | +0.00% |
| ▲ Q2 FY2024 | May 14, 2024 | +5.2% | $5.99 | $6.07 | +1.34% |
Q2 FY2026+1.08%
Report Date
May 14, 2026
EPS Beat/Miss
-4.3%
Price Before
$8.35
Price After
$8.44
Q1 FY2026+0.00%
Report Date
Feb 18, 2026
EPS Beat/Miss
+141.2%
Price Before
$7.79
Price After
$7.79
Q3 FY2025+7.22%
Report Date
Aug 13, 2025
EPS Beat/Miss
+111.8%
Price Before
$6.51
Price After
$6.98
Q2 FY2025+0.00%
Report Date
May 14, 2025
EPS Beat/Miss
+93.5%
Price Before
$6.07
Price After
$6.07
Q1 FY2025+0.00%
Report Date
Mar 5, 2025
EPS Beat/Miss
-229.5%
Price Before
$5.40
Price After
$5.40
Q4 FY2024+0.00%
Report Date
Nov 13, 2024
EPS Beat/Miss
+48.1%
Price Before
$5.98
Price After
$5.98
Q3 FY2024+0.00%
Report Date
Aug 13, 2024
EPS Beat/Miss
-36.8%
Price Before
$6.34
Price After
$6.34
Q2 FY2024+1.34%
Report Date
May 14, 2024
EPS Beat/Miss
+5.2%
Price Before
$5.99
Price After
$6.07
Avg Beat Reaction+1.71%
Avg Miss Reaction+0.36%
Beat Rate5 / 8 quarters
Largest Move+7.22% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: KPTSF ends December
KP Tissue Inc. (KPTSF) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.16 — missing the analyst consensus of $0.17 by -4.3%. The next KPTSF earnings date is expected around September 1, 2026.
Each quarter, investors track KPTSF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KPTSF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
KPTSF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
KPTSF earnings · 5 questionsKP Tissue Inc.'s next earnings report is expected around September 1, 2026. KPTSF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KPTSF historically reports after market close (AMC).
KPTSF earnings datewhen is KPTSF earningsKPTSF next earnings datewhen does KPTSF report earningsKPTSF earnings calendar
▸ Source: FMP · KP Tissue Inc. SEC filings · US GAAP · KP Tissue Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026